The Sigma Healthcare Ltd (ASX: SIG) share price is in focus after the company announced it has withdrawn from the potential acquisition of The Boots Group. The company says this decision follows a preliminary review of the sale process.
What did Sigma Healthcare report?
- Sigma has ceased all discussions regarding the purchase of The Boots Group.
- The Board determined the acquisition would not meet current strategic or capital investment objectives.
- International growth remains a key strategic pillar for Sigma.
- Recent Memorandum of Understanding signed with Greenlight Healthcare to explore UK market opportunities.
What else do investors need to know?
Sigma had been considering the Boots acquisition to accelerate its expansion in the UK, leveraging Boots’ well-established brand and presence. After initial investigations, Sigma found that the deal did not align with its strategic aims or capital discipline.
The company reiterated its commitment to international growth, particularly in core offshore markets, while continuing to assess new market opportunities. Sigma also stressed its confidence in its current growth strategy, which prioritises strengthening its position in the Australian market.
What’s next for Sigma Healthcare?
Looking ahead, Sigma says it will keep assessing acquisition opportunities in Australia and internationally that align with its strategy and offer sustainable returns to shareholders. The company’s focus remains on its established plans, including the recent MoU with Greenlight Healthcare, as it seeks growth through disciplined investment and partnering in key markets.
Sigma Healthcare share price snapshot
Over the past 12 months, Sigma Healthcare shares have declined 19%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 4% over the same period.
The post Sigma Healthcare withdraws from Boots sale process appeared first on The Motley Fool Australia.
Should you invest $1,000 in Sigma Healthcare right now?
Before you buy Sigma Healthcare shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sigma Healthcare wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Elders confirms Killara Feedlot sale completion for June 2026
- Perseus Mining expands share buy-back to $150 million: June 2026 update
- Atlas Arteria: Takeover offer lifted to $5.10 per security
- IperionX snaps up rare earths assets to strengthen U.S. critical minerals position
- Transurban earnings: M7-M12 project and A25 sale boost outlook
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.